Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
High flow nasal cannula oxygen therapy has been widely used in critically ill patients. Despite effectiveness of high flow nasal cannula as a treatment, optimal methods to withdrawal high flow nasal cannula after recovery from preexisting conditions has not been investigated to date. In this study, we will evaluate the efficacy and safety of three different weaning methods in patients with high flow nasal cannula oxygen therapy.
Comparison of three weaning strategies: flow reduction first versus fraction of inspired oxygen (FiO2) first versus simultaneous reduction
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Flow reduction first group | Active Comparator | Flow reduction first -> FiO2 reduction -> conventional oxygen therapy |
|
| FiO2 reduction first group | Active Comparator | FiO2 reduction first -> flow reduction -> conventional oxygen therapy |
|
| Simultaneous reduction group | Active Comparator | Simultaneous (Flow and FiO2) reduction -> conventional oxygen therapy |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Flow reduction first | Device | -10L/min q 1hr |
| |
| Measure | Description | Time Frame |
|---|---|---|
| Time to weaning success | The time to successfully remaining off high flow nasal cannula | up to 2 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| weaning success or failure rate | Success or failure rate to wean off high flow nasal cannula | up to 2 weeks |
| change of arterial partial pressure of oxygen, carbon dioxide, and pH | changes of arterial blood gas analyses |
Not provided
Inclusion Criteria:
The patients applying high flow nasal cannula and satisfying the following weaning criteria.
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Eun Sun Kim, MD | Seoul National University Bundang Hospital | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Seoul National University Bundang Hospital | Seongnam-si | Gyeonggi-do | 13620 | South Korea |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 31937322 | Derived | Kim MC, Lee YJ, Park JS, Cho YJ, Yoon HI, Lee CT, Lee JH, Kim ES. Simultaneous reduction of flow and fraction of inspired oxygen (FiO2) versus reduction of flow first or FiO2 first in patients ready to be weaned from high-flow nasal cannula oxygen therapy: study protocol for a randomized controlled trial (SLOWH trial). Trials. 2020 Jan 14;21(1):81. doi: 10.1186/s13063-019-4019-7. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D012131 | Respiratory Insufficiency |
| ID | Term |
|---|---|
| D012120 | Respiration Disorders |
| D012140 | Respiratory Tract Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| FiO2 reduction first |
| Device |
- 0.1 q 1hr |
|
| Simultaneous (flow and FiO2) reduction | Device | -10L/min and -0.1 q 1hr |
|
| up to 2 weeks |
| intolerance rate | intolerance to high flow nasal cannula | up to 2 weeks |
| hospital length of stay | hospital length of stay | during hospital admission, up to 12 weeks |
| In-hospital mortality | all cause mortality | during hospital admission, up to 12 weeks |